Additionally, FYB overexpression is associated with breast cancer metastasis and breast cancer recurrence and has been identified as a potential marker for ductal carcinoma in situ (DCIS) and infiltrating ductal carcinoma (IDC) in the breast; thus, FYB exhibits potential for breast cancer diagnosis and prevention [22]. This evidence concerns the gene FYB1 and ductal breast carcinoma in situ.